Literature DB >> 8732179

Quantification of biomedical NMR data using artificial neural network analysis: lipoprotein lipid profiles from 1H NMR data of human plasma.

M Ala-Korpela1, Y Hiltunen, J D Bell.   

Abstract

Artificial neural network (ANN) analysis is a new technique in NMR spectroscopy. It is very often considered only as an efficient "black-box' tool for data classification, but we emphasize here that ANN analysis is also powerful for data quantification. The possibility of finding out the biochemical rationale controlling the ANN outputs is presented and discussed. Furthermore, the characteristics of ANN analysis, as applied to plasma lipoprotein lipid quantification, are compared to those of sophisticated lineshape fitting (LF) analysis. The performance of LF in this particular application is shown to be less satisfactory when compared to neural networks. The lipoprotein lipid quantification represents a regular clinical need and serves as a good example of an NMR spectroscopic case of extreme signal overlap. The ANN analysis enables quantification of lipids in very low, intermediate, low and high density lipoprotein (VLDL, IDL, LDL and HDL, respectively) fractions directly from a 1H NMR spectrum of a plasma sample in < 1 h. The ANN extension presented is believed to increase the value of the 1H NMR based lipoprotein quantification to the point that it could be the method of choice in some advanced research settings. Furthermore, the excellent quantification performance of the ANN analysis, demonstrated in this study, serves as an indication of the broad potential of neural networks in biomedical NMR.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8732179     DOI: 10.1002/nbm.1940080603

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  7 in total

1.  Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum.

Authors:  Ville-Petteri Mäkinen; Pasi Soininen; Carol Forsblom; Maija Parkkonen; Petri Ingman; Kimmo Kaski; Per-Henrik Groop; Mika Ala-Korpela
Journal:  MAGMA       Date:  2006-12-15       Impact factor: 2.310

2.  1H NMR spectroscopy quantifies visibility of lipoproteins, subclasses, and lipids at varied temperatures and pressures.

Authors:  Daniela Baumstark; Werner Kremer; Alfred Boettcher; Christina Schreier; Paul Sander; Gerd Schmitz; Renate Kirchhoefer; Fritz Huber; Hans Robert Kalbitzer
Journal:  J Lipid Res       Date:  2019-06-25       Impact factor: 5.922

3.  Predicting arterial blood gas values from venous samples in patients with acute exacerbation chronic obstructive pulmonary disease using artificial neural network.

Authors:  Mohammad Reza Raoufy; Parivash Eftekhari; Shahriar Gharibzadeh; Mohammad Reza Masjedi
Journal:  J Med Syst       Date:  2009-11-04       Impact factor: 4.460

4.  Leuconostoc mesenteroides growth in food products: prediction and sensitivity analysis by adaptive-network-based fuzzy inference systems.

Authors:  Hue-Yu Wang; Ching-Feng Wen; Yu-Hsien Chiu; I-Nong Lee; Hao-Yun Kao; I-Chen Lee; Wen-Hsien Ho
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

5.  A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data.

Authors:  Aki Vehtari; Ville-Petteri Mäkinen; Pasi Soininen; Petri Ingman; Sanna M Mäkelä; Markku J Savolainen; Minna L Hannuksela; Kimmo Kaski; Mika Ala-Korpela
Journal:  BMC Bioinformatics       Date:  2007-05-03       Impact factor: 3.169

Review 6.  Lipidomics unveils the complexity of the lipidome in metabolic diseases.

Authors:  Todd A Lydic; Young-Hwa Goo
Journal:  Clin Transl Med       Date:  2018-01-26

7.  1H-NMR and MALDI-TOF MS as metabolomic quality control tests to classify platelet derived medium additives for GMP compliant cell expansion procedures.

Authors:  Francesco Agostini; Marta Ruzza; Davide Corpillo; Luca Biondi; Elena Acquadro; Barbara Canepa; Alessandra Viale; Monica Battiston; Fabrizio Serra; Silvio Aime; Mario Mazzucato
Journal:  PLoS One       Date:  2018-09-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.